/PRNewswire/ Galvanize Therapeutics, Inc. today announced the treatment of the first patient in the AFFINITY clinical study. This prospective trial is.
/PRNewswire/ Galvanize Therapeutics, Inc., a leader in developing pulsed electric field (PEF) therapies for COPD, soft tissue, and cardiac arrhythmias, has.
/PRNewswire/ Galvanize Therapeutics, Inc. today announced the first human investigational use of its large-area, focal, Pulsed Electric Field (PEF) ablation.